+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Rapid Microbiology Testing Market Size, Share & Trends Analysis Report By Method, By Application , By Product (Instruments , Reagents & Kits, and Consumables), By Country and Growth Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 172 Pages
  • April 2024
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5955372
The Asia Pacific Rapid Microbiology Testing Market would witness market growth of 11.3% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Rapid Microbiology Testing Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $792.4 million by 2031. The Japan market is registering a CAGR of 10.6% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 12% during (2024 - 2031).



Unnecessary antibiotic use is a significant driver of antimicrobial resistance, contributing to the proliferation of drug-resistant pathogens and the erosion of antibiotic effectiveness. This testing aids in the timely identification of infectious agents and their susceptibility to antibiotics, allowing healthcare providers to differentiate between bacterial and viral infections and avoid inappropriate antibiotic prescribing. By providing actionable diagnostic information within hours rather than days, rapid testing technologies empower healthcare providers to make evidence-based decisions regarding antibiotic therapy, reducing the overuse and misuse of antibiotics and preserving their effectiveness for future generations.

Furthermore, continuous innovation and technology developments to improve the speed, accuracy, and accessibility of infectious disease diagnoses characterize the market. Molecular diagnostics technologies like nucleic acid amplification assays are at the forefront of this testing innovation. Polymerase chain reaction, loop-mediated isothermal amplification, and nucleic acid sequencing platforms enable the rapid and sensitive detection of microbial nucleic acids, offering high specificity and multiplexing capabilities for identifying multiple pathogens in a single test.

Pharmaceutical manufacturers in India rely on these testing solutions for in-process monitoring, environmental monitoring, and finished product testing throughout the manufacturing process. Rapid testing technologies facilitate the timely detection of microbial contaminants, including bacteria, fungi, and endotoxins, in raw materials, intermediate products, and finished pharmaceutical formulations. As per the data released in 2023 by the India Brand Equity Foundation, it is expected that the Indian pharmaceuticals sector will attain a value of US$65 billion by 2024 and US$130 billion by 2030. The Indian pharmaceutical industry is estimated to be worth around $50 billion, of which more than $25 billion is derived from exports, according to government data. Therefore, with the growing pharmaceutical sector in Asia Pacific, there will be increased demand in the region.

Based on Method, the market is segmented into Growth-based Rapid Microbiology Testing, Cellular Component-based Rapid Microbiology Testing, Nucleic Acid-based Rapid Microbiology Testing, Viability-based Rapid Microbiology Testing and Others. Based on Application, the market is segmented into Industrial Testing (Food & Beverage Testing, Pharmaceutical & Biological Drug Testing, Environmental Testing, Cosmetics & Personal Care Products Testing and Others), Clinical Disease Diagnosis and Research Applications. Based on Product, the market is segmented into Instruments (Automated Microbial Identification & Antimicrobial Susceptibility Testing Systems, Mass Spectrometers, PCR Systems, Bioluminescence & Fluorescence-based Detection Systems, Cytometers, Active Air Samplers and Others), Reagents & Kits, and Consumables. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

  • BioMerieux S.A.
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Bruker Corporation
  • QuidelOrtho Corporation
  • Charles River Laboratories International, Inc.
  • Neogen Corporation

Market Report Segmentation

By Method
  • Growth-based Rapid Microbiology Testing
  • Cellular Component-based Rapid Microbiology Testing
  • Nucleic Acid-based Rapid Microbiology Testing
  • Viability-based Rapid Microbiology Testing
  • Others
By Application
  • Industrial Testing
  • Food & Beverage Testing
  • Pharmaceutical & Biological Drug Testing
  • Environmental Testing
  • Cosmetics & Personal Care Products Testing
  • Others
  • Clinical Disease Diagnosis
  • Research Applications
By Product
  • Instruments
  • Automated Microbial Identification & Antimicrobial Susceptibility Testing Systems
  • Mass Spectrometers
  • PCR Systems
  • Bioluminescence & Fluorescence-based Detection Systems
  • Cytometers
  • Active Air Samplers
  • Others
  • Reagents & Kits
  • Consumables
By Country
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Malaysia
  • Rest of Asia Pacific

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Rapid Microbiology Testing Market, by Method
1.4.2 Asia Pacific Rapid Microbiology Testing Market, by Application
1.4.3 Asia Pacific Rapid Microbiology Testing Market, by Product
1.4.4 Asia Pacific Rapid Microbiology Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Trials and Approvals
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.4.2 Key Strategic Move: (Product Launches and Product Expansions: 2020, Aug - 2023, May) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Asia Pacific Rapid Microbiology Testing Market by Method
5.1 Asia Pacific Growth-based Rapid Microbiology Testing Market by Country
5.2 Asia Pacific Cellular Component-based Rapid Microbiology Testing Market by Country
5.3 Asia Pacific Nucleic Acid-based Rapid Microbiology Testing Market by Country
5.4 Asia Pacific Viability-based Rapid Microbiology Testing Market by Country
5.5 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Rapid Microbiology Testing Market by Application
6.1 Asia Pacific Industrial Testing Market by Country
6.2 Asia Pacific Rapid Microbiology Testing Market by Industrial Testing Type
6.2.1 Asia Pacific Food & Beverage Testing Market by Country
6.2.2 Asia Pacific Pharmaceutical & Biological Drug Testing Market by Country
6.2.3 Asia Pacific Environmental Testing Market by Country
6.2.4 Asia Pacific Cosmetics & Personal Care Products Testing Market by Country
6.2.5 Asia Pacific Others Market by Country
6.3 Asia Pacific Clinical Disease Diagnosis Market by Country
6.4 Asia Pacific Research Applications Market by Country
Chapter 7. Asia Pacific Rapid Microbiology Testing Market by Product
7.1 Asia Pacific Instruments Market by Country
7.2 Asia Pacific Rapid Microbiology Testing Market by Instruments Type
7.2.1 Asia Pacific Automated Microbial Identification & Antimicrobial Susceptibility Testing Systems Market by Country
7.2.2 Asia Pacific Mass Spectrometers Market by Country
7.2.3 Asia Pacific PCR Systems Market by Country
7.2.4 Asia Pacific Bioluminescence & Fluorescence-based Detection Systems Market by Country
7.2.5 Asia Pacific Cytometers Market by Country
7.2.6 Asia Pacific Active Air Samplers Market by Country
7.2.7 Asia Pacific Others Market by Country
7.3 Asia Pacific Reagents & Kits Market by Country
7.4 Asia Pacific Consumables Market by Country
Chapter 8. Asia Pacific Rapid Microbiology Testing Market by Country
8.1 China Rapid Microbiology Testing Market
8.1.1 China Rapid Microbiology Testing Market by Method
8.1.2 China Rapid Microbiology Testing Market by Application
8.1.2.1 China Rapid Microbiology Testing Market by Industrial Testing Type
8.1.3 China Rapid Microbiology Testing Market by Product
8.1.3.1 China Rapid Microbiology Testing Market by Instruments Type
8.2 Japan Rapid Microbiology Testing Market
8.2.1 Japan Rapid Microbiology Testing Market by Method
8.2.2 Japan Rapid Microbiology Testing Market by Application
8.2.2.1 Japan Rapid Microbiology Testing Market by Industrial Testing Type
8.2.3 Japan Rapid Microbiology Testing Market by Product
8.2.3.1 Japan Rapid Microbiology Testing Market by Instruments Type
8.3 India Rapid Microbiology Testing Market
8.3.1 India Rapid Microbiology Testing Market by Method
8.3.2 India Rapid Microbiology Testing Market by Application
8.3.2.1 India Rapid Microbiology Testing Market by Industrial Testing Type
8.3.3 India Rapid Microbiology Testing Market by Product
8.3.3.1 India Rapid Microbiology Testing Market by Instruments Type
8.4 South Korea Rapid Microbiology Testing Market
8.4.1 South Korea Rapid Microbiology Testing Market by Method
8.4.2 South Korea Rapid Microbiology Testing Market by Application
8.4.2.1 South Korea Rapid Microbiology Testing Market by Industrial Testing Type
8.4.3 South Korea Rapid Microbiology Testing Market by Product
8.4.3.1 South Korea Rapid Microbiology Testing Market by Instruments Type
8.5 Australia Rapid Microbiology Testing Market
8.5.1 Australia Rapid Microbiology Testing Market by Method
8.5.2 Australia Rapid Microbiology Testing Market by Application
8.5.2.1 Australia Rapid Microbiology Testing Market by Industrial Testing Type
8.5.3 Australia Rapid Microbiology Testing Market by Product
8.5.3.1 Australia Rapid Microbiology Testing Market by Instruments Type
8.6 Malaysia Rapid Microbiology Testing Market
8.6.1 Malaysia Rapid Microbiology Testing Market by Method
8.6.2 Malaysia Rapid Microbiology Testing Market by Application
8.6.2.1 Malaysia Rapid Microbiology Testing Market by Industrial Testing Type
8.6.3 Malaysia Rapid Microbiology Testing Market by Product
8.6.3.1 Malaysia Rapid Microbiology Testing Market by Instruments Type
8.7 Rest of Asia Pacific Rapid Microbiology Testing Market
8.7.1 Rest of Asia Pacific Rapid Microbiology Testing Market by Method
8.7.2 Rest of Asia Pacific Rapid Microbiology Testing Market by Application
8.7.2.1 Rest of Asia Pacific Rapid Microbiology Testing Market by Industrial Testing Type
8.7.3 Rest of Asia Pacific Rapid Microbiology Testing Market by Product
8.7.3.1 Rest of Asia Pacific Rapid Microbiology Testing Market by Instruments Type
Chapter 9. Company Profiles
9.1 BioMerieux S.A.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 QuidelOrtho Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Trials and Approvals:
9.3 Merck KGaA
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 Neogen Corporation
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.4.6 SWOT Analysis
9.5 Danaher Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.5.6 SWOT Analysis
9.6 Abbott Laboratories
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Product launches and Product expansions:
9.6.6 SWOT Analysis
9.7 Thermo Fisher Scientific, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.7.6 SWOT Analysis
9.8 Bruker Corporation
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Product Launches and Product Expansions:
9.8.6 SWOT Analysis
9.9 Charles River Laboratories International, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 SWOT Analysis
9.10. Becton, Dickinson, and Company
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
9.10.5 Recent strategies and developments:
9.10.5.1 Partnerships, Collaborations, and Agreements:
9.10.6 SWOT Analysis

Companies Mentioned

  • BioMerieux S.A.
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Bruker Corporation
  • QuidelOrtho Corporation
  • Charles River Laboratories International, Inc.
  • Neogen Corporation

Methodology

Loading
LOADING...